Mihael H. Polymeropoulos

2015

In 2015, Mihael H. Polymeropoulos earned a total compensation of $2.4M as President and Chief Executive Officer at Vanda Pharmaceuticals, a 12% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$396,000
Option Awards$756,000
Salary$600,000
Stock Awards$595,500
Other$19,214
Total$2,366,714

Polymeropoulos received $756K in option awards, accounting for 32% of the total pay in 2015.

Polymeropoulos also received $396K in non-equity incentive plan, $600K in salary, $595.5K in stock awards and $19.2K in other compensation.

Rankings

In 2015, Mihael H. Polymeropoulos' compensation ranked 4,062nd out of 13,638 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 70.2% of executives.

ClassificationRankingPercentile
All
4,062
out of 13,638
70th
Division
Manufacturing
1,482
out of 5,190
71st
Major group
Chemicals And Allied Products
540
out of 1,854
71st
Industry group
Drugs
428
out of 1,528
72nd
Industry
Pharmaceutical Preparations
336
out of 1,182
72nd
Source: SEC filing on April 27, 2017.

Polymeropoulos' colleagues

We found five more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2015.

2015

Richard Gulino

Vanda Pharmaceuticals

General Counsel

2015

Gian Reverberi

Vanda Pharmaceuticals

Senior Vice President, Chief Commercial Officer

2015

Thomas Gibbs

Vanda Pharmaceuticals

Former Senior Vice President, Chief Commercial Officer

2015

James Kelly

Vanda Pharmaceuticals

Chief Financial Officer

2015

Paolo Baroldi

Vanda Pharmaceuticals

Chief Medical Officer

News

You may also like